Clinical Trial Update: Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports on the safety and efficacy of donafenib in patients with advanced hepatocellular carcinoma across Phase 1 and Phase 2 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Donafenib (donafenib)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: HCC | Phase 1, Phase 2 | Status: COMPLETED